Spectral Med Inc is seeing a drop in its stock price, which has investors concerned.
Spectral Med Inc (EDT.TO) saw its stock fall by 2.13% today, closing at CA$1.15. This decline comes despite the company making progress in regulatory processes and clinical trials, leaving investors wondering what’s behind this downturn.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$346.39M
52W high
$1.65
52W low
$1.03
1W change
+2.61%
Beta
0.18
Analyst Price Targets
Based on analyst covering EDT · as of Sep 17, 2026
Wall Street analysts forecast EDT stock price to rise 166.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+166.9% Upside
Current Price
C$1.18
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
38.1%
Annualized
90-Day Vol
31.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.99
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.11 | C$0.97 – C$1.27 |
| 60 trading days | C$1.05 | C$0.87 – C$1.26 |
| 90 trading days | C$0.99 | C$0.79 – C$1.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should stay cautious as the stock faces downward pressure, even with the company’s positive developments.
Stock slides 2.13% in one day
Spectral Med Inc's market cap is now CA$346 million, reflecting how investors feel about the recent decline.
Bull case
Spectral Med Inc has made important progress in its PMX therapy, which could lead to growth if it gets the necessary regulatory approvals.
Bear case
The current stock slide might signal deeper concerns about the company’s financial health or the market conditions, which could affect future performance.
Current Stock Performance
Advertisement
Spectral Med Inc's stock is down 2.13% in today’s trading session, closing at CA$1.15. This decline raises questions about how the market feels about the company, especially given its recent announcements about clinical trials and regulatory submissions.
Investor Concerns
Even with positive news in the company’s pipeline, like the PMA application for PMX, investors are cautious about the stock's recent performance. The market cap of CA$346 million suggests that confidence may be slipping, and the current slide could reflect broader market trends or specific worries about the company’s financial health.
Looking Ahead
As Spectral Med Inc continues through its regulatory processes, investors will be paying close attention to updates that could affect the stock's direction. While the company has made significant strides, the recent stock slide highlights the volatility that often comes with biotech investments.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
